Response to fulvestrant in heavily pretreated postmenopausal women: a single-center experienceFRANCO, Sandra; PEREZ, Alejandra; TAN-CHIU, Elizabeth et al.Breast cancer research and treatment. 2004, Vol 88, Num 2, pp 103-108, issn 0167-6806, 6 p.Article

Wavefront analysis and Zernike polynomial decomposition for evaluation of corneal optical qualityOLIVEIRA, Cristina M; FERREIRA, Andreia; FRANCO, Sandra et al.Journal of cataract and refractive surgery. 2012, Vol 38, Num 2, pp 343-356, issn 0886-3350, 14 p.Article

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancerMORENO-ASPITIA, Alvaro; DUECK, Amylou C; RODEHEFFER, Richard et al.Breast cancer research and treatment. 2013, Vol 138, Num 2, pp 427-435, issn 0167-6806, 9 p.Article

Outbreak of nosocomial hepatitis C virus infection resolved by genetic analysis of HCV RNABRUGUERA, Miguel; SAIZ, Juan-Carlos; FRANCO, Sandra et al.Journal of clinical microbiology (Print). 2002, Vol 40, Num 11, pp 4363-4366, issn 0095-1137, 4 p.Article

IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patientsFRANCO, Sandra; APARICIO, Ester; PARERA, Mariona et al.AIDS (London). 2014, Vol 28, Num 1, pp 133-136, issn 0269-9370, 4 p.Article

Accommodative and Convergence Response to Computer Screen and Printed TextFERREIRA, Andreia; LIRA, Madalena; FRANCO, Sandra et al.Proceedings of SPIE, the International Society for Optical Engineering. 2011, Vol 8001, issn 0277-786X, isbn 978-0-8194-8575-5, 2Vol, 800139.1-800139.8, 2Conference Paper

Fluorescence Resonance Energy Transfer-Based Assay for Characterization of Hepatitis C Virus NS3-4A Protease Activity in Live CellsSABARIEGOS, Rosario; PICAZO, Fernando; DOMINGO, Beatriz et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 2, pp 728-734, issn 0066-4804, 7 p.Article

Alleles at rs4273729 in the chromosome 6 do not predict response to peg-interferon-α and ribavirin therapy in hepatitis C virus/HIV-1-coinfected patientsFRANCO, Sandra; TURAL, Cristina; CLOTET, Bonaventura et al.AIDS (London). 2012, Vol 26, Num 15, pp 1973-1974, issn 0269-9370, 2 p.Article

Complexity and Catalytic Efficiency of Hepatitis C Virus (HCV) NS3 and NS4A Protease Quasispecies Influence Responsiveness to Treatment with Pegylated Interferon plus Ribavirin in HCV/HIV-Coinfected PatientsAPARICIO, Ester; FRANCO, Sandra; PARERA, Mariona et al.Journal of virology. 2011, Vol 85, Num 12, pp 5961-5969, issn 0022-538X, 9 p.Article

Comparison of the VCTS-6500 and the CSV-1000 tests for visual contrast sensitivity testingFRANCO, Sandra; SILVA, Ana Carolina; CARVALHO, Ana Sofia et al.Neurotoxicology (Park Forest South). 2010, Vol 31, Num 6, pp 758-761, issn 0161-813X, 4 p.Article

Genetic and catalytic efficiency structure of an hcv protease quasispeciesFRANCO, Sandra; PARERA, Mariona; APARICIO, Ester et al.Hepatology (Baltimore, Md.). 2007, Vol 45, Num 4, pp 899-910, issn 0270-9139, 12 p.Article

Phase i trial and antitumor effects of BZL101 for patients with advanced breast cancerRUGO, Hope; SHTIVELMAN, Emma; TRAN, Zung et al.Breast cancer research and treatment. 2007, Vol 105, Num 1, pp 17-28, issn 0167-6806, 12 p.Article

A new optical system for 3-dimensional mapping of the corneaFRANCO, Sandra; ALMEIDA, José B.Progress in biomedical optics and imaging. 2007, pp 66311J.1-66311J.7, issn 1605-7422, isbn 978-0-8194-6775-1, 1VolConference Paper

Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection: indications for the investigation of new treatment approachesBALLESTEROS, Angel Luis; FRANCO, Sandra; CLOTET, Bonaventura et al.AIDS (London). 2004, Vol 18, Num 1, pp 59-66, issn 0269-9370, 8 p.Article

Characterization and evolution of NS5A quasispecies of hepatitis C virus genotype 1b in patients with different stages of liver diseaseFRANCO, Sandra; GIMENEZ-BARCONS, Mireia; PUIG-BASAGOITI, Francesc et al.Journal of medical virology. 2003, Vol 71, Num 2, pp 195-204, issn 0146-6615, 10 p.Article

High amino acid variability within the ns5a of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-lb-related cirrhosisGIMENEZ-BARCONS, Mireia; FRANCO, Sandra; SANCHEZ-TAPIAS, José-Maria et al.Hepatology (Baltimore, Md.). 2001, Vol 34, Num 1, pp 158-167, issn 0270-9139Article

Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis C virus on the response to interferon therapy in chronic hepatitis CPUIG-BASAGOITI, Francesc; SAIZ, Juan-Carlos; FORNS, Xavier et al.Journal of medical virology. 2001, Vol 65, Num 1, pp 35-44, issn 0146-6615Article

A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancerRUGO, Hope S; JO CHIEN, A; NULSEN, Ben et al.Breast cancer research and treatment. 2012, Vol 134, Num 1, pp 13-20, issn 0167-6806, 8 p.Article

A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancerRIXE, Olivier; FRANCO, Sandra X; YARDLEY, Denise A et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 6, pp 1139-1148, issn 0344-5704, 10 p.Article

Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast CancerGOMEZ, Henry L; DOVAL, Dinesh C; CASEY, Michelle A et al.Journal of clinical oncology. 2008, Vol 26, Num 18, pp 2999-3005, issn 0732-183X, 7 p.Article